Cargando…
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
Neutralizing antibodies (nAbs) to highly variable viral pathogens show remarkable diversification during infection, resulting in an “arms race” between virus and host. Studies of nAb lineages have shown how somatic hypermutation (SHM) in immunoglobulin (Ig)-variable regions enables maturing antibodi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723817/ https://www.ncbi.nlm.nih.gov/pubmed/33238131 http://dx.doi.org/10.1016/j.celrep.2020.108430 |
_version_ | 1783620422227460096 |
---|---|
author | Scheepers, Cathrine Bekker, Valerie Anthony, Colin Richardson, Simone I. Oosthuysen, Brent Moyo, Thandeka Kgagudi, Prudence Kitchin, Dale Nonyane, Molati York, Talita Mielke, Dieter Mabvakure, Batsirai M. Sheng, Zizhang Lambson, Bronwen E. Ismail, Arshad Garrett, Nigel J. Karim, Salim S. Abdool Shapiro, Lawrence Williamson, Carolyn Morris, Lynn Moore, Penny L. |
author_facet | Scheepers, Cathrine Bekker, Valerie Anthony, Colin Richardson, Simone I. Oosthuysen, Brent Moyo, Thandeka Kgagudi, Prudence Kitchin, Dale Nonyane, Molati York, Talita Mielke, Dieter Mabvakure, Batsirai M. Sheng, Zizhang Lambson, Bronwen E. Ismail, Arshad Garrett, Nigel J. Karim, Salim S. Abdool Shapiro, Lawrence Williamson, Carolyn Morris, Lynn Moore, Penny L. |
author_sort | Scheepers, Cathrine |
collection | PubMed |
description | Neutralizing antibodies (nAbs) to highly variable viral pathogens show remarkable diversification during infection, resulting in an “arms race” between virus and host. Studies of nAb lineages have shown how somatic hypermutation (SHM) in immunoglobulin (Ig)-variable regions enables maturing antibodies to neutralize emerging viral escape variants. However, the Ig-constant region (which determines isotype) can also influence epitope recognition. Here, we use longitudinal deep sequencing of an HIV-directed nAb lineage, CAP88-CH06, and identify several co-circulating isotypes (IgG3, IgG1, IgA1, IgG2, and IgA2), some of which share identical variable regions. First, we show that IgG3 and IgA1 isotypes are better able to neutralize longitudinal autologous viruses and epitope mutants than can IgG1. Second, detrimental class-switch recombination (CSR) events that resulted in reduced neutralization can be rescued by further CSR, which we term “switch redemption.” Thus, CSR represents an additional immunological mechanism to counter viral escape from HIV-specific antibody responses. |
format | Online Article Text |
id | pubmed-7723817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-77238172020-12-09 Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape Scheepers, Cathrine Bekker, Valerie Anthony, Colin Richardson, Simone I. Oosthuysen, Brent Moyo, Thandeka Kgagudi, Prudence Kitchin, Dale Nonyane, Molati York, Talita Mielke, Dieter Mabvakure, Batsirai M. Sheng, Zizhang Lambson, Bronwen E. Ismail, Arshad Garrett, Nigel J. Karim, Salim S. Abdool Shapiro, Lawrence Williamson, Carolyn Morris, Lynn Moore, Penny L. Cell Rep Article Neutralizing antibodies (nAbs) to highly variable viral pathogens show remarkable diversification during infection, resulting in an “arms race” between virus and host. Studies of nAb lineages have shown how somatic hypermutation (SHM) in immunoglobulin (Ig)-variable regions enables maturing antibodies to neutralize emerging viral escape variants. However, the Ig-constant region (which determines isotype) can also influence epitope recognition. Here, we use longitudinal deep sequencing of an HIV-directed nAb lineage, CAP88-CH06, and identify several co-circulating isotypes (IgG3, IgG1, IgA1, IgG2, and IgA2), some of which share identical variable regions. First, we show that IgG3 and IgA1 isotypes are better able to neutralize longitudinal autologous viruses and epitope mutants than can IgG1. Second, detrimental class-switch recombination (CSR) events that resulted in reduced neutralization can be rescued by further CSR, which we term “switch redemption.” Thus, CSR represents an additional immunological mechanism to counter viral escape from HIV-specific antibody responses. 2020-11-24 /pmc/articles/PMC7723817/ /pubmed/33238131 http://dx.doi.org/10.1016/j.celrep.2020.108430 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0). |
spellingShingle | Article Scheepers, Cathrine Bekker, Valerie Anthony, Colin Richardson, Simone I. Oosthuysen, Brent Moyo, Thandeka Kgagudi, Prudence Kitchin, Dale Nonyane, Molati York, Talita Mielke, Dieter Mabvakure, Batsirai M. Sheng, Zizhang Lambson, Bronwen E. Ismail, Arshad Garrett, Nigel J. Karim, Salim S. Abdool Shapiro, Lawrence Williamson, Carolyn Morris, Lynn Moore, Penny L. Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape |
title | Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape |
title_full | Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape |
title_fullStr | Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape |
title_full_unstemmed | Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape |
title_short | Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape |
title_sort | antibody isotype switching as a mechanism to counter hiv neutralization escape |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723817/ https://www.ncbi.nlm.nih.gov/pubmed/33238131 http://dx.doi.org/10.1016/j.celrep.2020.108430 |
work_keys_str_mv | AT scheeperscathrine antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT bekkervalerie antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT anthonycolin antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT richardsonsimonei antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT oosthuysenbrent antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT moyothandeka antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT kgagudiprudence antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT kitchindale antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT nonyanemolati antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT yorktalita antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT mielkedieter antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT mabvakurebatsiraim antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT shengzizhang antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT lambsonbronwene antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT ismailarshad antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT garrettnigelj antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT karimsalimsabdool antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT shapirolawrence antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT williamsoncarolyn antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT morrislynn antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape AT moorepennyl antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape |